{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:45:01Z","timestamp":1778877901316,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"7771","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1038\/s41586-019-1472-0","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T18:03:36Z","timestamp":1565201016000},"page":"676-680","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells"],"prefix":"10.1038","volume":"572","author":[{"given":"David N.","family":"Debruyne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Dries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyaki","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Seruggia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bandana","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"McLane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathanael S.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwok-Kin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart H.","family":"Orkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Cheng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rani E.","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,7]]},"reference":[{"key":"1472_CR1","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature11082","volume":"485","author":"JR Dixon","year":"2012","unstructured":"Dixon, J. R. et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485, 376\u2013380 (2012).","journal-title":"Nature"},{"key":"1472_CR2","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cell.2013.04.053","volume":"153","author":"JE Phillips-Cremins","year":"2013","unstructured":"Phillips-Cremins, J. E. et al. Architectural protein subclasses shape 3D organization of genomes during lineage commitment. Cell 153, 1281\u20131295 (2013).","journal-title":"Cell"},{"key":"1472_CR3","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1126\/science.aad9024","volume":"351","author":"D Hnisz","year":"2016","unstructured":"Hnisz, D. et al. Activation of proto-oncogenes by disruption of chromosome neighborhoods. Science 351, 1454\u20131458 (2016).","journal-title":"Science"},{"key":"1472_CR4","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/ng.3335","volume":"47","author":"R Katainen","year":"2015","unstructured":"Katainen, R. et al. CTCF\/cohesin-binding sites are frequently mutated in cancer. Nat. Genet. 47, 818\u2013821 (2015).","journal-title":"Nat. Genet."},{"key":"1472_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature16490","volume":"529","author":"WA Flavahan","year":"2016","unstructured":"Flavahan, W. A. et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529, 110\u2013114 (2016).","journal-title":"Nature"},{"key":"1472_CR6","doi-asserted-by":"publisher","first-page":"6806","DOI":"10.1073\/pnas.092123699","volume":"99","author":"DI Loukinov","year":"2002","unstructured":"Loukinov, D. I. et al. BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma. Proc. Natl Acad. Sci. USA 99, 6806\u20136811 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1472_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S1044-579X(02)00060-3","volume":"12","author":"EM Klenova","year":"2002","unstructured":"Klenova, E. M., Morse, H. C. III, Ohlsson, R. & Lobanenkov, V. V. The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. Semin. Cancer Biol. 12, 399\u2013414 (2002).","journal-title":"Semin. Cancer Biol."},{"key":"1472_CR8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.ejca.2011.09.009","volume":"48","author":"I Martin-Kleiner","year":"2012","unstructured":"Martin-Kleiner, I. BORIS in human cancers \u2014 a review. Eur. J. Cancer 48, 929\u2013935 (2012).","journal-title":"Eur. J. Cancer"},{"key":"1472_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbrc.2017.01.066","volume":"484","author":"KR Garikapati","year":"2017","unstructured":"Garikapati, K. R. et al. Down-regulation of BORIS\/CTCFL efficiently regulates cancer stemness and metastasis in MYCN amplified neuroblastoma cell line by modulating Wnt\/\u03b2-catenin signaling pathway. Biochem. Biophys. Res. Commun. 484, 93\u201399 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1472_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrc3526","volume":"13","author":"NK Cheung","year":"2013","unstructured":"Cheung, N. K. & Dyer, M. A. Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nat. Rev. Cancer 13, 397\u2013411 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"1472_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/molehr\/gan025","volume":"14","author":"M Monk","year":"2008","unstructured":"Monk, M., Hitchins, M. & Hawes, S. Differential expression of the embryo\/cancer gene ECSA(DPPA2), the cancer\/testis gene BORIS and the pluripotency structural gene OCT4, in human preimplantation development. Mol. Hum. Reprod. 14, 347\u2013355 (2008).","journal-title":"Mol. Hum. Reprod."},{"key":"1472_CR12","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1126\/science.6719137","volume":"224","author":"GM Brodeur","year":"1984","unstructured":"Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E. & Bishop, J. M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224, 1121\u20131124 (1984).","journal-title":"Science"},{"key":"1472_CR13","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nature07397","volume":"455","author":"RE George","year":"2008","unstructured":"George, R. E. et al. Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature 455, 975\u2013978 (2008).","journal-title":"Nature"},{"key":"1472_CR14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1073\/pnas.0609412103","volume":"104","author":"AV Galkin","year":"2007","unstructured":"Galkin, A. V. et al. Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK. Proc. Natl Acad. Sci. USA 104, 270\u2013275 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1472_CR15","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.cell.2014.10.024","volume":"159","author":"E Chipumuro","year":"2014","unstructured":"Chipumuro, E. et al. CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer. Cell 159, 1126\u20131139 (2014).","journal-title":"Cell"},{"key":"1472_CR16","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/s41588-018-0191-z","volume":"50","author":"AD Durbin","year":"2018","unstructured":"Durbin, A. D. et al. Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry. Nat. Genet. 50, 1240\u20131246 (2018).","journal-title":"Nat. Genet."},{"key":"1472_CR17","first-page":"2579","volume":"9","author":"L van der Maaten","year":"2008","unstructured":"van der Maaten, L. & Hinton, G. Visualizing data using t-SNE. J. Mach. Learn. Res. 9, 2579\u20132605 (2008).","journal-title":"J. Mach. Learn. Res."},{"key":"1472_CR18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41588-018-0044-9","volume":"50","author":"R Zeid","year":"2018","unstructured":"Zeid, R. et al. Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma. Nat. Genet. 50, 515\u2013523 (2018).","journal-title":"Nat. Genet."},{"key":"1472_CR19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1126\/science.aao2793","volume":"360","author":"M Muhar","year":"2018","unstructured":"Muhar, M. et al. SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis. Science 360, 800\u2013805 (2018).","journal-title":"Science"},{"key":"1472_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.tins.2005.08.008","volume":"28","author":"M Wegner","year":"2005","unstructured":"Wegner, M. & Stolt, C. C. From stem cells to neurons and glia: a Soxist\u2019s view of neural development. Trends Neurosci. 28, 583\u2013588 (2005).","journal-title":"Trends Neurosci."},{"key":"1472_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.chembiol.2017.11.007","volume":"25","author":"Y Gao","year":"2018","unstructured":"Gao, Y. et al. Overcoming resistance to the THZ series of covalent transcriptional CDK inhibitors. Cell Chem. Biol. 25, 135\u2013142 (2018).","journal-title":"Cell Chem. Biol."},{"key":"1472_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0736-8","volume":"16","author":"EM Pugacheva","year":"2015","unstructured":"Pugacheva, E. M. et al. Comparative analyses of CTCF and BORIS occupancies uncover two distinct classes of CTCF binding genomic regions. Genome Biol. 16, 161 (2015).","journal-title":"Genome Biol."},{"key":"1472_CR23","doi-asserted-by":"publisher","first-page":"7097","DOI":"10.1093\/nar\/gky483","volume":"46","author":"P Bergmaier","year":"2018","unstructured":"Bergmaier, P. et al. Choice of binding sites for CTCFL compared to CTCF is driven by chromatin and by sequence preference. Nucleic Acids Res. 46, 7097\u20137107 (2018).","journal-title":"Nucleic Acids Res."},{"key":"1472_CR24","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nmeth.3999","volume":"13","author":"MR Mumbach","year":"2016","unstructured":"Mumbach, M. R. et al. HiChIP: efficient and sensitive analysis of protein-directed genome architecture. Nat. Methods 13, 919\u2013922 (2016).","journal-title":"Nat. Methods"},{"key":"1472_CR25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cell.2014.09.030","volume":"159","author":"JM Dowen","year":"2014","unstructured":"Dowen, J. M. et al. Control of cell identity genes occurs in insulated neighborhoods in mammalian chromosomes. Cell 159, 374\u2013387 (2014).","journal-title":"Cell"},{"key":"1472_CR26","doi-asserted-by":"publisher","first-page":"E6456","DOI":"10.1073\/pnas.1518552112","volume":"112","author":"AL Sanborn","year":"2015","unstructured":"Sanborn, A. L. et al. Chromatin extrusion explains key features of loop and domain formation in wild-type and engineered genomes. Proc. Natl Acad. Sci. USA 112, E6456\u2013E6465 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1472_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","volume":"153","author":"WA Whyte","year":"2013","unstructured":"Whyte, W. A. et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307\u2013319 (2013).","journal-title":"Cell"},{"key":"1472_CR28","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","volume":"155","author":"D Hnisz","year":"2013","unstructured":"Hnisz, D. et al. Super-enhancers in the control of cell identity and disease. Cell 155, 934\u2013947 (2013).","journal-title":"Cell"},{"key":"1472_CR29","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00018-008-8335-4","volume":"66","author":"JP Kumar","year":"2009","unstructured":"Kumar, J. P. The sine oculis homeobox (SIX) family of transcription factors as regulators of development and disease. Cell. Mol. Life Sci. 66, 565\u2013583 (2009).","journal-title":"Cell. Mol. Life Sci."},{"key":"1472_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.brainres.2018.03.013","volume":"1705","author":"DJ Dennis","year":"2019","unstructured":"Dennis, D. J., Han, S. & Schuurmans, C. bHLH transcription factors in neural development, disease, and reprogramming. Brain Res. 1705, 48\u201365 (2019).","journal-title":"Brain Res."},{"key":"1472_CR31","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1158\/0008-5472.CAN-04-0377","volume":"64","author":"S Batra","year":"2004","unstructured":"Batra, S., Reynolds, C. P. & Maurer, B. J. Fenretinide cytotoxicity for Ewing\u2019s sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators. Cancer Res. 64, 5415\u20135424 (2004).","journal-title":"Cancer Res."},{"key":"1472_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0165-4608(86)90001-4","volume":"21","author":"J Whang-Peng","year":"1986","unstructured":"Whang-Peng, J. et al. Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet. Cytogenet. 21, 185\u2013208 (1986).","journal-title":"Cancer Genet. Cytogenet."},{"key":"1472_CR33","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos, P. et al. Selective inhibition of BET bromodomains. Nature 468, 1067\u20131073 (2010).","journal-title":"Nature"},{"key":"1472_CR34","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1021\/jm400402q","volume":"56","author":"TH Marsilje","year":"2013","unstructured":"Marsilje, T. H. et al. Synthesis, structure\u2013activity relationships, and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase (ALK) inhibitor 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) currently in phase 1 and phase 2 clinical trials. J. Med. Chem. 56, 5675\u20135690 (2013).","journal-title":"J. Med. Chem."},{"key":"1472_CR35","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1021\/jm500261q","volume":"57","author":"TW Johnson","year":"2014","unstructured":"Johnson, T. W. et al. Discovery of (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) with preclinical brain exposure and broad-spectrum potency against ALK-resistant mutations. J. Med. Chem. 57, 4720\u20134744 (2014).","journal-title":"J. Med. Chem."},{"key":"1472_CR36","doi-asserted-by":"publisher","first-page":"8111","DOI":"10.1021\/jm5010539","volume":"57","author":"R Gosmini","year":"2014","unstructured":"Gosmini, R. et al. The discovery of I-BET726 (GSK1324726A), a potent tetrahydroquinoline ApoA1 up-regulator and selective BET bromodomain inhibitor. J. Med. Chem. 57, 8111\u20138131 (2014).","journal-title":"J. Med. Chem."},{"key":"1472_CR37","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.cell.2012.10.012","volume":"151","author":"J Lov\u00e9n","year":"2012","unstructured":"Lov\u00e9n, J. et al. Revisiting global gene expression analysis. Cell 151, 476\u2013482 (2012).","journal-title":"Cell"},{"key":"1472_CR38","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1038\/onc.2015.434","volume":"35","author":"DN Debruyne","year":"2016","unstructured":"Debruyne, D. N. et al. ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT. Oncogene 35, 3681\u20133691 (2016).","journal-title":"Oncogene"},{"key":"1472_CR39","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1126\/science.1157535","volume":"320","author":"Y Sancak","year":"2008","unstructured":"Sancak, Y. et al. The Rag GTPases bind Raptor and mediate amino acid signaling to mTORC1. Science 320, 1496\u20131501 (2008).","journal-title":"Science"},{"key":"1472_CR40","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1073\/pnas.1019736108","volume":"108","author":"KL Meerbrey","year":"2011","unstructured":"Meerbrey, K. L. et al. The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc. Natl Acad. Sci. USA 108, 3665\u20133670 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1472_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/BF00300234","volume":"24","author":"MM Tomayko","year":"1989","unstructured":"Tomayko, M. M. & Reynolds, C. P. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol. 24, 148\u2013154 (1989).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"1472_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049","volume":"8","author":"GX Zheng","year":"2017","unstructured":"Zheng, G. X. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).","journal-title":"Nat. Commun."},{"key":"1472_CR43","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier, L., Cope, L., Bolstad, B. M. & Irizarry, R. A. affy\u2014analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307\u2013315 (2004).","journal-title":"Bioinformatics"},{"key":"1472_CR44","first-page":"111","volume":"224","author":"GK Smyth","year":"2003","unstructured":"Smyth, G. K., Yang, Y. H. & Speed, T. Statistical issues in cDNA microarray data analysis. Methods Mol. Biol. 224, 111\u2013136 (2003).","journal-title":"Methods Mol. Biol."},{"key":"1472_CR45","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"1472_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0831-x","volume":"16","author":"N Servant","year":"2015","unstructured":"Servant, N. et al. HiC-Pro: an optimized and flexible pipeline for Hi-C data processing. Genome Biol. 16, 259 (2015).","journal-title":"Genome Biol."},{"key":"1472_CR47","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/bioinformatics\/btx623","volume":"34","author":"CA Lareau","year":"2018","unstructured":"Lareau, C. A. & Aryee, M. J. diffloop: a computational framework for identifying and analyzing differential DNA loops from sequencing data. Bioinformatics 34, 672\u2013674 (2018).","journal-title":"Bioinformatics"},{"key":"1472_CR48","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.stem.2015.11.007","volume":"18","author":"X Ji","year":"2016","unstructured":"Ji, X. et al. 3D chromosome regulatory landscape of human pluripotent cells. Cell Stem Cell 18, 262\u2013275 (2016).","journal-title":"Cell Stem Cell"},{"key":"1472_CR49","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576\u2013589 (2010).","journal-title":"Mol. Cell"},{"key":"1472_CR50","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nbt.2957","volume":"32","author":"SEQC\/MAQC-III Consortium","year":"2014","unstructured":"SEQC\/MAQC-III Consortium. A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium. Nat. Biotechnol. 32, 903\u2013914 (2014).","journal-title":"Nat. Biotechnol."},{"key":"1472_CR51","first-page":"168712","volume":"2011","author":"S Savola","year":"2011","unstructured":"Savola, S. et al. High expression of complement component 5 (C5) at tumor site associates with superior survival in Ewing\u2019s sarcoma family of tumour patients. ISRN Oncol. 2011, 168712 (2011).","journal-title":"ISRN Oncol."},{"key":"1472_CR52","first-page":"438","volume":"17","author":"S Huang","year":"2015","unstructured":"Huang, S. et al. Analytical performance of a 15-gene prognostic assay for early-stage non-small-cell lung carcinoma using RNA-stabilized tissue. JMD 17, 438\u2013445 (2015).","journal-title":"JMD"},{"key":"1472_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-2-34","volume":"2","author":"M Li","year":"2009","unstructured":"Li, M. et al. Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer. BMC Med. Genomics 2, 34 (2009).","journal-title":"BMC Med. Genomics"},{"key":"1472_CR54","doi-asserted-by":"publisher","first-page":"6871","DOI":"10.1158\/0008-5472.CAN-08-4490","volume":"69","author":"L Liu","year":"2009","unstructured":"Liu, L. et al. Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL. Cancer Res. 69, 6871\u20136878 (2009).","journal-title":"Cancer Res."},{"key":"1472_CR55","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-06-4180","volume":"67","author":"D Beier","year":"2007","unstructured":"Beier, D. et al. CD133+ and CD133\u2212 glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 67, 4010\u20134015 (2007).","journal-title":"Cancer Res."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1472-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1472-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1472-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:58:25Z","timestamp":1684619905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-019-1472-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":55,"journal-issue":{"issue":"7771","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1472"],"URL":"https:\/\/doi.org\/10.1038\/s41586-019-1472-0","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"21 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.S.G. is a founder, SAB member and equity holder of Gatekeeper, Syros Pharmaceuticals, Petra, C4, B2S and Soltego. The Gray laboratory receives or has received research funding from Novartis, Takeda, Astellas, Taiho, Janssen, Kinogen, Voronoi, Her2llc, Deerfield and Sanofi. S.H.O. is a SAB member of Syros. R.A.Y. is a founder and shareholder of Syros, Camp4 Therapeutics, Omega Therapeutics and Dewpoint Therapeutics. R.E.G. is a SAB member of Global Gene Corp.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}